Blood Cancer United's Equity in Access Research Program was created to help ensure more equitable access to care for blood cancer patients and survivors.
Through this program, Blood Cancer United aims to generate new evidence that can guide policy reform and changes in healthcare practice, in order to mitigate the impact of social, economic and environmental disadvantages and reduce barriers to care. Learn about our 2025 Equity in Access Research Program grantees and their research following this year’s application information.
The purpose of this Request for Proposals (RFP) is to fund research that advances understanding of how insurance status, type, design, and policy changes create barriers to equitable access to cancer care, and that identifies actionable solutions to address these barriers through policy reform and changes in healthcare practice and program delivery.
| Webinar for prospective applicants | June 17, 2026 (1:30PM ET) | |
|---|---|---|
| Deadline to submit Letters of Intent | September 10, 2026 (3PM ET) | |
| Blood Cancer United notifies applicants whether they are invited to submit full proposal | November 12, 2026 | |
| Deadline for receipt of full proposals (invited applicants) | February 4, 2027 (3PM ET) | |
| Notification of awards | July 2027 | |
| Grant start date | October 1, 2027 | |